A detailed history of Isam Funds (Uk) LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Isam Funds (Uk) LTD holds 7,530 shares of BMY stock, worth $411,966. This represents 0.23% of its overall portfolio holdings.

Number of Shares
7,530
Holding current value
$411,966
% of portfolio
0.23%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $303,082 - $399,014
7,530 New
7,530 $313 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $197,907 - $234,350
2,890 New
2,890 $208 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $116B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Isam Funds (Uk) LTD Portfolio

Follow Isam Funds (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Isam Funds (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Isam Funds (Uk) LTD with notifications on news.